Fluvirin (Seqirus Inc.)
Welcome to the PulseAid listing for the Fluvirin drug offered from Seqirus Inc.. This Inactivated Influenza B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | Seqirus Inc. |
NON-PROPRIETARY NAME: | A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/B |
SUBSTANCE NAME: | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIR |
TYPE: | VACCINE |
PHARMA CLASS: | Inactivated Influenza B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-07-01 |
END MARKETING DATE: | 2018-06-30 |
Fluvirin VACCINE Details:
Item Description | Fluvirin from Seqirus Inc. |
LABELER NAME: | Seqirus Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL) |
START MARKETING DATE: | 2017-07-01 |
END MARKETING DATE: | 2018-06-30 |
PRODUCT ID: | 70461-120_b483a28e-2233-4285-b755-267b9f166dc9 |
PRODUCT NDC: | 70461-120 |
APPLICATION NUMBER: | BLA103837 |
Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIR Pharmaceutical Manufacturers / Labelers: